Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

BioMed Central full text link BioMed Central Free PMC article
Full text links

Actions

Review
.2025 Aug 11;18(1):148.
doi: 10.1186/s12245-025-00924-1.

Neuro-ophthalmology and migraine: visual aura and its neural basis

Affiliations
Review

Neuro-ophthalmology and migraine: visual aura and its neural basis

Hajar Nasir Tukur et al. Int J Emerg Med..

Abstract

Background: Migraine, a chronic neurological condition often accompanied by visual aura, which affects 15-33% of migraineurs, often presents as transient visual disturbances such as scintillating scotoma and teichopsia. These symptoms arise primarily from cortical spreading depression (CSD) within the occipital cortex and significantly impacts the quality of life, with chronic and episodic migraineurs consistently scoring lower scores in vision-specific quality of life questionnaires. Therefore, this narrative review explores the pathophysiology pertaining to visual aura in migraines, focusing on the role of CSD while evaluating current diagnostic and therapeutic approaches employed.

Methods: A narrative literature review was conducted using PubMed and ScienceDirect, focusing on studies published between 2000 and 2025. Search terms related to "migraine", "visual aura", and "cortical spreading depression" were used to identify relevant original research, reviews, and clinical studies addressing the pathophysiology, diagnosis, and treatment of migraine-related visual aura.

Results: Findings indicate that CSD drove transient visual symptoms by triggering waves of neuronal depolarization and hypoperfusion in the visual cortex. Contemporaneous treatment modalities target the headache phase of migraine, with limited alternatives for aura-specific intervention.

Conclusion: Advancement in neuroimaging and genetic research offer promising avenues for early diagnosis alongside focused therapeutics for migraine with aura. However, current treatment strategies remain largely focused on the headache phase, with limited efficacy for aura-specific symptoms. Future therapeutic approaches targeting cortical spreading depression may offer more precise interventions for managing visual aura in migraine.

Keywords: Cortical spreading depression; Fortification spectra; Migraine; Migraine management; Neuro-ophthalmology; Neuroimaging; Scintillating scotoma; Visual aura.

© 2025. The Author(s).

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. All co-authors approved the final manuscript. All co-authors have read and approved the submission. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematic representation of cortical spreading depression (CSD) and headache in migraine with aura. The CSD wavefront (↑K⁺, ↓Ca²⁺, ↑glutamate) spreads across the cortex, leading to vascular changes, initial increase in blood flow (hyperemia) followed by reduced perfusion (hypoperfusion), contributing to aura symptoms. This activates the trigeminovascular system via the trigeminal ganglion and complex, which are involved in transmitting pain signals from the meninges and cranial blood vessels to the brainstem and cortex. This then relays nociceptive signals to the thalamus and results in pain perception. Arrows indicate the direction of signal propagation
See this image and copyright information in PMC

References

    1. Lucas C. Migraine with aura. Rev Neurol (Paris). 2021;177(7):779–84. 10.1016/j.neurol.2021.07.010. - DOI - PubMed
    1. Vuralli D, Karatas H, Yemisci M, Bolay H. Updated review on the link between cortical spreading depression and headache disorders. Expert Rev Neurother. 2021;21(10):1069–84. 10.1080/14737175.2021.1947797. - DOI - PubMed
    1. Kim KM, Kim BK, Lee W, Hwang H, Heo K, Chu MK. Prevalence and impact of visual aura in migraine and probable migraine: a population study. Sci Rep. 2022;12(1):426. 10.1038/s41598-021-04250-3. - DOI - PMC - PubMed
    1. Viana M, Sances G, Linde M, Ghiotto N, Guaschino E, Allena M, et al. Clinical features of migraine aura: results from a prospective diary-aided study. Cephalalgia. 2017;37(10):979–89. 10.1177/0333102416657147. - DOI - PubMed
    1. Viana M, Hougaard A, Tronvik E, Winnberg IG, Ambrosini A, Perrotta A, et al. Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura. Cephalalgia. 2024;44(2):03331024241234809. 10.1177/03331024241234809. - DOI - PubMed

Publication types

LinkOut - more resources

Full text links
BioMed Central full text link BioMed Central Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp